2-29072199-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001029883.3(PCARE):c.2063G>A(p.Cys688Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00658 in 1,614,218 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C688F) has been classified as Uncertain significance.
Frequency
Consequence
NM_001029883.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PCARE | NM_001029883.3 | c.2063G>A | p.Cys688Tyr | missense_variant | 1/2 | ENST00000331664.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PCARE | ENST00000331664.6 | c.2063G>A | p.Cys688Tyr | missense_variant | 1/2 | 2 | NM_001029883.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00537 AC: 818AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00504 AC: 1257AN: 249574Hom.: 4 AF XY: 0.00514 AC XY: 696AN XY: 135398
GnomAD4 exome AF: 0.00670 AC: 9797AN: 1461894Hom.: 44 Cov.: 51 AF XY: 0.00650 AC XY: 4730AN XY: 727248
GnomAD4 genome ? AF: 0.00537 AC: 818AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.00524 AC XY: 390AN XY: 74484
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Apr 18, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | PCARE: BP4, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 29, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 08, 2014 | - - |
Retinitis pigmentosa 54 Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Apr 17, 2020 | - - |
Retinitis pigmentosa Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at